PROCEPT BioRobotics Corporation
General ticker "PRCT" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.1B (TTM average)
PROCEPT BioRobotics Corporation does not follow the US Stock Market performance with the rate: -11.7%.
Estimated limits based on current volatility of 4.8%: low 31.01$, high 34.16$
Factors to consider:
- Total employees count: 756 (+20.8%) as of 2024
- US accounted for 35.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Manufacturing disruptions, Supply chain disruptions, Cybersecurity threats, Regulatory and compliance
- Current price 21.8% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [45.32$, 105.62$]
- 2025-12-31 to 2026-12-31 estimated range: [31.76$, 78.18$]
Financial Metrics affecting the PRCT estimates:
- Negative: with PPE of -46.5 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.33 <= 0.33
- Positive: Shareholder equity ratio, % of 75.32 > 63.39
- Positive: Investing cash flow per share per price, % of -0.10 > -0.66
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
Short-term PRCT quotes
Long-term PRCT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $75.01MM | $136.19MM | $224.50MM |
| Operating Expenses | $155.74MM | $245.36MM | $321.11MM |
| Operating Income | $-80.72MM | $-109.17MM | $-96.61MM |
| Non-Operating Income | $-6.43MM | $3.27MM | $5.20MM |
| Interest Expense | $5.18MM | $4.00MM | $4.18MM |
| R&D Expense | $28.98MM | $48.45MM | $62.30MM |
| Income(Loss) | $-87.15MM | $-105.90MM | $-91.41MM |
| Profit(Loss)* | $-87.15MM | $-105.90MM | $-91.41MM |
| Stockholders Equity | $197.07MM | $280.75MM | $402.22MM |
| Inventory | $28.54MM | $39.76MM | $56.17MM |
| Assets | $309.33MM | $404.72MM | $534.02MM |
| Operating Cash Flow | $-80.38MM | $-108.00MM | $-99.21MM |
| Capital expenditure | $2.65MM | $25.21MM | $4.41MM |
| Investing Cash Flow | $-2.65MM | $-25.21MM | $-4.41MM |
| Financing Cash Flow | $3.61MM | $167.79MM | $180.12MM |
| Earnings Per Share** | $-1.96 | $-2.24 | $-1.75 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.